Spire Healthcare Group (LON:SPI) Raised to Buy at Peel Hunt
Peel Hunt upgraded shares of Spire Healthcare Group (LON:SPI) to a buy rating in a research note issued to investors on Thursday, Stock Target Advisor reports.
A number of other equities analysts also recently commented on SPI. UBS Group upped their target price on Spire Healthcare Group from GBX 117 ($1.54) to GBX 121 ($1.59) and gave the company a neutral rating in a report on Tuesday, February 11th. Royal Bank of Canada decreased their target price on Spire Healthcare Group from GBX 149 ($1.96) to GBX 100 ($1.32) and set an outperform rating for the company in a report on Wednesday. Peel Hunt restated an add rating and set a GBX 155 ($2.04) target price on shares of Spire Healthcare Group in a report on Wednesday, January 8th. Liberum Capital restated a hold rating on shares of Spire Healthcare Group in a report on Wednesday. Finally, Barclays restated an underweight rating on shares of Spire Healthcare Group in a report on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company. Spire Healthcare Group currently has a consensus rating of Hold and a consensus price target of GBX 130.44 ($1.72).
Shares of Spire Healthcare Group stock traded up GBX 0.05 ($0.00) during midday trading on Thursday, reaching GBX 52.60 ($0.69). 5,252,477 shares of the company’s stock traded hands, compared to its average volume of 1,770,000. The company has a debt-to-equity ratio of 124.33, a quick ratio of 0.77 and a current ratio of 1.03. The company has a market cap of $210.97 million and a PE ratio of 29.22. The stock has a 50 day moving average of GBX 114.54 and a 200-day moving average of GBX 121.36. Spire Healthcare Group has a 12 month low of GBX 61.25 ($0.81) and a 12 month high of GBX 145 ($1.91).
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Recommended Story: Investing in Growth Stocks
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.